International Patent: USE OF GRFT AND FUSION PROTEIN GREK1 THEREOF IN INHIBITING PARAMYXOVIRUS OR NOVEL CORONAVIRUS INFECTIONS

GENEVA, Nov. 6 -- SHANXI JINBO BIO-PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/135776) for “USE OF GRFT AND FUSION PROTEIN GREK1 THEREOF IN INHIBITING PARAMYXOVIRUS OR NOVEL CORONAVIRUS INFECTIONS”. With publication no. WO/2026/227737, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/16

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....